Clinical Study on the Efficacy and Safety of Telitacicept in the Treatment of Pediatric IgA Nephropathy or IgA Vasculitis Nephritis
NCT07052981
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
124
Enrollment
OTHER
Sponsor class
Conditions
IgA Nephropathy (IgAN)
IgAVN
Interventions
DRUG:
Telitacicept
Sponsor
Guixia Ding